Physician profile
Patrick Mclaren
NPI 1922366764
$9,034.56
in general payments reported to CMS, 2019-2025
29 companies · $49.72 in 2025
The $49.72 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,826 · 2020: $159 · 2021: $945 · 2022: $256 · 2023: $3,678 · 2024: $121 · 2025: $49.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,842 · Education: $1,000 · Food and Beverage: $990 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,842.35 |
| Education | $1,000.00 |
| Food and Beverage | $989.94 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,355.79 | 2019-2023 | Da Vinci Surgical System, Davinci Xi |
| Medtronic USA, INC. | $722.94 | 2019 | |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Medtronic, INC. | $273.59 | 2021-2022 | |
| Boston Scientific Corporation | $241.53 | 2019-2022 | |
| Sirtex Medical INC | $158.76 | 2020 | |
| Baxter Healthcare | $110.00 | 2021 | |
| Allergan, INC. | $101.81 | 2021 | |
| Becton, Dickinson and Company | $79.86 | 2023-2024 | Phasix Mesh |
| Stryker Corporation | $73.17 | 2023 | Spy-Phi System, 1688 |
| Takeda Pharmaceuticals U.S.A., INC. | $71.86 | 2021-2023 | Gattex |
| Abbvie INC. | $66.75 | 2021 | |
| Alcresta Therapeutics, INC. | $55.02 | 2023-2024 | Relizorb |
| Fresenius Kabi USA, LLC | $46.86 | 2021 | |
| Solventum Corporation | $36.77 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $33.82 | 2023 | Exparel |
| Ethicon US, LLC | $33.39 | 2023 | Certus 140 |
| Kowa Pharmaceuticals America, INC. | $32.40 | 2023 | Seglentis |
| Jazz Pharmaceuticals INC. | $30.92 | 2025 | |
| Integra Lifesciences Corporation | $28.54 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Davol INC. | $25.91 | 2023 | Arista Ah Flexitip |
| Tela Bio, INC. | $25.26 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $24.99 | 2024 | Irrisept |
| Cook Biotech Incorporated | $23.24 | 2023 | Fortify Flowable |
| W. L. Gore & Associates, INC. | $20.79 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $18.80 | 2025 | Somatuline Depot, Onivyde |
| Lifenet Health | $13.61 | 2023 | |
| Endo Pharmaceuticals INC. | $11.91 | 2021 | |
| Eisai INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mclaren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.